Citations

Showing 10 of 108152 citations.

Abstract 582: Overexpression of Catalase Impairs Aortic Valve Function and Accelerates Valvular Calification in Mice
Roos, Carolyn M, Casaclang‐Verzosa, Grace , Fermoyle, Caitlin C. , Zhang, Bin , Miller, Jordan D.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 21, 2021 | Volume: 36 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.36.suppl_1.582 Get It

Previous studies have reported increases in oxidative stress due to reductions in antioxidant enzymes in calcified regions of stenotic human aortic valves. Whether reductions in antioxidant enzymes are adaptive, maladaptive, or an epiphenomenon in calcifying aortic valves remains unclear. Thus, the purpose of this study was to test whether overexpression of catalase reduces valvular calcification and slows progression of aortic valve stenosis in mice. Wild type (WT) mice with calcific aortic valve disease (ldlr-deficient, apoB100-only) were crossed with transgenic mice that overexpress human catalase (TG). All mice were fed a western diet (TD88137; Harlan Teklad). Functional echocardiogram data was collected and analyzed at early (3 months) and advanced (12 months) stages of valve disease, and valves were OCT embedded, sectioned, and stained for calcium levels (Alizarin Red). The transgenic valves show a slight increase in calcification compared to wild type counterparts. While there were no differences in valve function between genotypes at the early time point, cusp separation was decreased in the transgenic mice (0.74 ± 0.02 mm) compared to their wild-type littermates (0.84 ± 0.03 mm) at the 12 month time point (p < 0.05). In a subset of animals, valve calcification also tended to increase in transgenic mice at both time points compared to their wild-type littermates. In conclusion, overexpression of catalase resulted in a surprising finding of accelerated valvular calcification and stenosis. Interestingly, this finding aligns with the findings from several negative clinical trials testing antioxidant therapies in humans with atherosclerosis, suggests that the net impact of changing redox balance on disease progression are highly context dependent, and that increasing antioxidant capacity may not be a viable strategy to slow progression of calcific aortic valve disease in humans.
Abstract 424: Transintestinal Cholesterol Excretion Can Drive Massive Cholesterol Elimination in Mice
Boer, Jan Freark de , Schonewille, Marleen, Boesjes, Marije, Wolters, Henk, Bos, Trijnie , Dijk, Theo H. van , Jurdzinski, Angelika, Boverhof, Renze, Deursen, Jan M. van , Kremoser, Claus, Groen, Albert K., Bloks, Vincent W. , Elferink, Ronald P.J. Oude , Moschetta, Antonio , Verkade, Henkjan J. , Kuipers, Folkert

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 21, 2021 | Volume: 36 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.36.suppl_1.424 Get It

High plasma cholesterol levels increase the risk of cardiovascular disease (CVD). Transintestinal Cholesterol Excretion (TICE) is a recently emerged pathway of cholesterol removal and has the potential to lower plasma cholesterol levels and confer protection against CVD. Under control conditions, TICE accounts for about 30% of fecal cholesterol loss in mice. Using a panel of knock-out and transgenic mice as well as pharmacological manipulations we show that in mice TICE is regulated by intestinal activation of the Farnesoid X Receptor (FXR), via its target Fibroblast Growth Factor 15/19 (FGF15/19). Activation of FXR by the agonist PX20606 (PX) resulted in a >10-fold increased fecal cholesterol excretion as well as TICE and 40% reduced plasma cholesterol levels. The induction of fecal cholesterol excretion and TICE was absent in PX-treated intestine-specific FXR-null mice but was regained when those mice were co-treated with FGF19. Moreover, FGF19 treatment alone was sufficient to induce fecal cholesterol loss to a similar extend as was observed in PX-treated wild-type mice. PX treatment resulted in an increased muricholate/cholate-ratio and thereby induced a more hydrophilic bile salt pool. Not surprisingly, cholesterol absorption was reduced in PX-treated mice. However, experiments in which mice were co-treated with PX and the cholesterol absorption inhibitor ezetimibe revealed that the stimulating effect of PX on fecal neutral sterol excretion and TICE were completely independent of differences in cholesterol absorption. Of note, treatment of mice with a combination of PX and ezetimibe stimulated fecal cholesterol loss and TICE so strongly that those mice lost about 60% of their entire estimated body cholesterol content each day. The stimulation of fecal cholesterol loss and TICE by PX and PX/ezetimibe treatment was severely blunted in Abcg8-KO mice and this could not be restored by hepatic reintroduction of Abcg8, indicating a decisive role for intestinal ABCG5/G8 in PX-induced fecal cholesterol loss and TICE. Our data strongly suggest that hydrophilic bile acids stimulate ABCG5/G8 activity in the intestine, leading to an increased flux of cholesterol from the body into the intestinal lumen that is subsequently excreted with the feces.
Abstract 330: Testicular Vein Thrombosis Etiology and Outcomes
Lenz, Charles J., Simmons, Benjamin, Cohoon, Kevin P. , Daniels, Paul R. , Saadiq, Rayya A. , McBane, Robert D. , Wysokiński, Waldemar E.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 21, 2021 | Volume: 36 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.36.suppl_1.330 Get It

Background: Testicular vein thrombosis (TVT) is not currently well-described in the literature. A better understanding of the natural history of TVT will allow for development of optimal management strategies for this little known entity. Methods: The goal of this project was to compare TVT with ovarian vein thrombosis (OVT) and lower extremity deep vein thrombosis (DVT). Patients with TVT, OVT, or DVT between 1995 and 2015 were identified and a chart review was performed. Results: A total of 39 patients with TVT occurring between 1995 and 2015 were identified and compared with 35 patients with OVT and 114 randomly chosen DVT patients. Mean duration of follow-up was 2.9 years (range 0-16.1). Patient demographics can be seen in table 1. Cancer-related (p-value=<0.0001) and idiopathic thrombosis (p-value=0.01) rates were significantly different among the groups. Recurrence rates were similar between TVT and OVT (4.2 vs. 3 per 100 patient-years, p-value = 0.9) as well as TVT and DVT (4.2 vs 2.2 recurrences per 100 patient-years, p-value= 0.37). There were 25 deaths (22%) in DVT patients, 9 (26%) in OVT patients, and 12 (31%) in TVT patients (p-value= 0.541). There was one major bleeding event in both an OVT patient and a TVT patient. Conclusion: Etiology of TVT differs from that of OVT and DVT, specifically in cancer-related and idiopathic thrombosis rate. Our data supports a similar rate of recurrent venous thromboembolism and death in TVT as compared with DVT and OVT.
Abstract 259: Genetic Inactivation of Sirt3 Does Not Alter Endothelial Function or Vascular Compliance in Hypercholesterolemic Mice
Roos, Carolyn M, Smith, Leslie A, Zhang, Bin , Ribeiro, Maurício Serra , Miller, Jordan D.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 21, 2021 | Volume: 36 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.36.suppl_1.259 Get It

Endothelial dysfunction and arterial stiffening major risk factors associated with progression of atherosclerosis and increased risk of acute coronary events. Recent data suggest sirtuins may play a role in protecting against a variety age-related diseases, and we recently reported that sirtuins are reduced in the aging vasculature. The roles of SIRT3 (a deacetylase that is largely restricted to the mitochondria) in the regulation of vasomotor function and arterial stiffness, however, remains poorly understood. Therefore, we hypothesized that genetic inactivation of SIRT3 in hypercholesterolemic mice will impair endothelial function and reduce vascular compliance compared to hypercholesterolemic mice with normal levels of SIRT3. We used Ldlr -/- /ApoB 100/100 (LA) mice that were either wild-type for SIRT3 (LA-SIRT3 +/+ ) or null for SIRT3 (LA-SIRT3 -/- ) and fed a western diet for 12 months. At time of sacrifice, aorta was removed for isolated organ chamber baths to measure changes in endothelium-dependent relaxation to acetylcholine (ACH), and carotid arteries were harvested to assess changes in vascular compliance using a pressurized cannulation system. Surprisingly, losses of SIRT3 did not impair relaxation to ACH in aorta compared to LA-SIRT3 +/+ mice (38.2±4.4%, 37.0±4.4%, respectively). Furthermore, reductions in SIRT3 did not impact vascular compliance or distensibility in carotid arteries from the same animals. In conclusion, in contrast to our hypothesis, inactivation of SIRT3 does not impact vasomotor function or conduit vessel compliance in advanced atherosclerosis. Importantly, this and may be explained by a “floor-effect”, and future work examining the effect of SIRT3 overexpression on vascular function and pathology will be instrumental in determining its biological role and ultimate therapeutic utility.
Abstract 109: Statins Have a Dose-dependent Effect on Amputation Risk and Survival in Peripheral Arterial Disease (PAD) Patients
Khakharia, Anjali , Brewster, Luke P. , Goodney, Philip P. , Arya, Shipra , Binney, Zachary O. , DeMartino, Randall R. , Wilson, Peter W.F.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 21, 2021 | Volume: 36 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.36.suppl_1.109 Get It

Introduction: Statin dose guidelines for PAD patients are based on coronary artery disease and stroke data. The aim of our study was to determine the effect of statin dose (based on 2013 ACC/AHA guidelines) on PAD outcomes of amputation and mortality. Methods: Patients with PAD in the Veterans Affairs database were identified from 2003-2014. The exposure was highest statin dose usage (none, low-moderate and high intensity) around diagnosis of PAD (within 1 year). The outcomes were risk of incident amputation (below knee or above knee) and mortality at 1, 3 and 5 years. The effect of statin dose on the two outcomes was also analyzed using Cox proportional hazards modeling to adjust for covariates. Results: In 208,275 patients with PAD [Males: 98.1%; Mean age: 67.4 yrs (SD 9.9)], 17,643 amputations and 99,951 deaths occurred in a median follow up of 5.2 years. Almost a quarter (27.7%) of patients were not on a statin while 30.4% were on simvastatin 80 mg (no longer recommended due to drug toxicity). The risk of incident amputation declined significantly at the high intensity statin dose as seen in Table 1. In Cox models adjusting for age, gender, race, comorbidities, cholesterol levels and creatinine, the high intensity statins were associated with lower amputation risk and mortality as compared to no statin [HR 0.67; 95% CI (0.63, 0.72) and HR 0.71; 95% CI (0.68, 0.73), respectively]. Low-moderate-dose statins also had significant but smaller reductions in risk of amputation and mortality [HR amputation 0.78 (0.75, 0.82), HR death 0.78 (0.77, 0.80)]. Conclusion: This is one of the largest population based studies to examine the effect of statins on long-term PAD outcomes and the first to explore the dose-dependent effect of statins on amputation and mortality. High intensity statins are associated with a significant reduction in limb loss and mortality in PAD patients followed by a smaller risk reduction by low-moderate intensity statins as compared to no statin therapy.
Pathophysiology of Cholangiocyte Cilia
LaRusso, Nicholas F.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 20 | Issue: 4 | Pages: No page available

10.1096/fasebj.20.4.a437-b Get It

Primary cilia are ubiquitous organelles found in most mammalian tissues. Recent studies suggest that they play an important role in epithelial cells, functioning as mechano‐, chemo‐ and/or osmo‐sensors. Moreover, morphological and functional ciliary abnormalities contribute to the development of different pathological conditions, in particular to autosomal dominant and recessive polycystic kidney and liver disease. However, information regarding the functions of primary cilia, particularly in the liver, is limited and how cilia respond to environmental stimuli is still poorly understood. Cholangiocytes, the epithelial cells lining intrahepatic bile ducts, each possess an individual cilium (approximately 7 μm in length) extending from the apical membrane into the ductal lumen with a typical 9+0 axoneme structure. They are heterogeneous in length along the biliary tree; i.e., in the large bile ducts, cilia are 2–3 times longer than in small ones. The strategic location of cholangiocyte cilia extending into the bile duct lumen raises questions about their role in sensing and transducting mechanical, chemical and osmotic signals between molecules in bile and cholangiocytes. Thus, development of novel approaches to study and isolate primary cilia are essential to understand the functions of these organelles. In this presentation, we will review the novel models we have developed to study cholangiocyte cilia, including: isolated perfused bile ducts from rat and mouse; cultured rodent cholangiocyte cell systems to evaluate ciliogenesis and cystogenesis; rodent models of cystic kidney and liver disease; and cell biologic techniques to isolate cilia. The application of these in vitro and in vivo techniques to hepatic cyst formation and expansion will also be emphasized.
Insulin sensitivity is not related to regional fat gain in lean men and women
Votruba, Susanne B. , Jensen, Michael D.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 20 | Issue: 4 | Pages: No page available

10.1096/fasebj.20.4.a425-d Get It

An upper body (UB) fat distribution is correlated with insulin resistance (IR). It is not known whether IR is caused by an UB fat distribution or if IR predisposes to UB fat gain. We recruited 25 lean volunteers to gain ~2 kg of body fat over ~8 weeks. We hypothesized that IR individuals would gain more UB fat than insulin sensitive individuals. At baseline, insulin sensitivity was assessed by 24‐hour insulin AUC over a meal controlled inpatient stay. Meal fat disposal was measured by the meal fat tracer/fat biopsy approach. Participants were grouped into tertiles based on their AUC insulin: least insulin sensitive tertile 1 (T1) = 37,449±2600; middle tertile 2 (T2) = 22,11±3002; most insulin sensitive tertile 3 (T3)= 13,233±2452 uU/ml/24h (mean±sem). At baseline, volunteers in the different tertiles had significantly different % body fat (T1=29±2%, T2=22±2%, and T3=18±2%; P<0.005). The T1 had more upper body subcutaneous (UBSQ) fat at baseline (8.3±0.5 kg) than the T3 (6.1±0.5 kg; P<0.05). Visceral and lower body subcutaneous (LBSQ) fat at baseline did not differ significantly between tertiles. Baseline meal fat storage in LBSQ fat was greater in T1 than T3 (20.9±3.4% vs. 9.0±1.9%, P < 0.05). Changes in regional fat gain as a percentage of total fat gain was not different by tertiles (53.3±2.7%, 8.3±2.0%, and 37.8±1.8%, for UBSQ, visceral, and LBSQ). Baseline insulin sensitivity was not predictive of the proportion of fat gain in the visceral or UBSQ regions. This argues against the hypothesis that insulin resistance results in UB fat gain. The alternative explanation is that those who gain UB fat eventually develop IR. T3 stored the least meal fat in the LBSQ region, suggesting that regional fat depots have differing responses to the prevailing insulinemia, perhaps through regulation of LPL activity.
Cyst‐lining epithelial cells from ADPKD kidneys have a mechano‐ciliary dysfunction
Nauli, Surya M. , Rossetti, Sandro, Kolb, Robert J., Consugar, Mark, Loghman‐Adham, Mahmoud, Zhou, Jing , Alenghat, Francis J. , Harris, Peter C. , Ingber, Donald E.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 20 | Issue: 4 | Pages: No page available

10.1096/fasebj.20.4.a339 Get It

Background Studies have shown that cilia are mechanical fluid shear sensors. We have reported previously that polycystins, ADPKD proteins, play a role in mechanosensation in mouse kidney epithelial cilia. Objective The current study was designed to analyze the functions of polycystins in human cells. Methods Epithelial cells were isolated from normal and ADPKD (both normal‐looking and dilated/cystic tubules) kidneys. These cells were subject to fluid shear analysis. Results Both immortalized and primary cultured renal tubular cells originating from normal human and non‐dilated ADPKD patient kidneys displayed normal ciliary expressions of the polycystins and responded to fluid flow shear stress with a change in cytosolic calcium. In contrast, immortalized and primary cultured cyst‐lining epithelial cells from ADPKD patients with PKD1 mutation or with abnormal ciliary expression of polycystins were not responsive to fluid shear stress. Conclusion Cyst‐lining epithelia in ADPKD kidneys have lost their ciliary mechanosensing ability. Thus, we propose that loss of mechanosensation in the renal tubular epithelia is a feature of the cyst lining epithelia and monitoring cytosolic calcium in this flow assay is a useful functional readout of polycystin function. This work is supported by the NIH and PKD foundation.
Infection and thrombotic risk: Role of TLR4 in platelet reactivity
Jayachandran, Muthuvel , Brunn, Gregory J., Karnicki, Krzysztof, Miller, Randall S., Owen, Whyte G., Miller, Virginia M.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 20 | Issue: 4 | Pages: No page available

10.1096/fasebj.20.4.a310-a Get It

Infection increases the risk of thrombotic disease. Platelets contribute to defense against infection and to thrombosis. Gram negative bacteria produce lipopolysaccharides (LPS) that activate Toll‐like‐receptor‐4 (TLR4) in the host and initiate inflammatory responses to infection. Platelets express TLR4, but whether or how LPS affects platelet functions that contribute to thrombotic disease is not understood. To determine if TLR4 signaling influences platelet functions that contribute to thrombotic disease, we studied responses of platelets from normal mice (C57BL/10SnJ; n=10) and mice that do not express TLR4 (C57BL/10ScN; dTLR4, n=10). Prior to LPS exposure, the number of circulating platelets, platelet RNA content and expression of P‐selectin following stimulation with thrombin were diminished in mice that lack TLR4 compared to wild type mice, while platelet aggregation and secretion of ATP were unchanged. These results suggest that loss of TLR4 function affects platelet production and membrane binding characteristics of the circulating platelet pool. One week following a single intravenous injection of LPS (200μg/kg/iv), the time it takes for the circulating platelet pool to turnover, both wild‐type and dTLR4 mice had similar numbers of circulating platelets, and thrombin‐induced expression of P‐selectin and platelet aggregation to collagen increased comparably in both groups of mice. These results indicate that TLR4 function is required for normal platelet homeostasis. Exposure to LPS stimulates a TLR4‐independent shift of the platelet pool toward a reactive phenotype, which could contribute to increased thrombotic risk during or following infection.
Non‐competitive Inhibition of ATP Binding to the Carboxyl Terminus of Kir6.2 by Epoxyeicosatrienoic Acids
Wang, Xiaoli , Cao, Sheng , Shah, Vijay H. , Lee, Hon‐Chi, Lü, Tong

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 20 | Issue: 4 | Pages: No page available

10.1096/fasebj.20.4.a487-a Get It

Epoxyeicosatrienoic acids (EETs) potently and stereospecifically activate the cardiac ATP‐sensitive K + (Kir6.2) channels by reducing channel sensitivity to ATP. In this study, we determined the effects of EETs on the binding of ATP to Kir6.2 by using 2,4,6‐trinitrophenyl (TNP)‐ATP, which increases fluorescence emission >8‐fold with binding to protein, and by using GST fusion protein containing Kir6.2. TNP‐ATP binds to the GST fusion protein containing the Kir6.2C‐terminus but not to that with the Kir6.2N‐terminus. Binding of TNP‐ATP to GST‐Kir6.2C (K D 5.0 μ M) was unchanged by 5 μ M 11,12‐EET (K D 4.4 μ M) but B max was reduced by half, suggesting non‐competitive inhibition of ATP binding. The effect of 11,12‐EET was dose‐dependent and 8,9‐ and 14,15‐EETs were equipotent inhibitors of TNP‐ATP binding to GST‐Kir6.2C. Arachidonic acid and 11,12‐DHET were not effective inhibitors, whereas the methyl ester of 11,12‐EET was as effective as 11,12‐EET in inhibiting TNP‐ATP binding to GST‐Kir6.2C. R195A mutation in GST‐Kir6.2C abolished the EET effects on TNP‐ATP binding, while the K185A mutation, which reduced ATP binding to Kir6.2, had no effect. These findings are consistent with previous patch clamp results that showed the epoxide group in EET and R195 in Kir6.2 are critical for K ATP channel activation by EET. We conclude that EETs bind to the C‐terminus of the K ATP channel and allosterically alter the ATP binding site, reducing the channel sensitivity to ATP.